Adalta Ltd has released a press release.
Chinese patent granted for AD-214
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from AdAlta
- Change in Director Interest Notice x 4
- Application for quotation of securities - 1AD
- Entitlement Offer Results
- Presentation to Share Cafe Webinar
- Presentation Conference Schedule - January 2022
Later from AdAlta
- $1.6M Second Tranche R&D Cash Flow Loan Received
- PAC Partners Healthcare Conference - Corporate Presentation
- Inhaled AD-214 preclinical program
- Indian patent for AD-214
- AdAlta presentation at Bioshares Biotech Summit
Follow AdAlta into a list and get an email when it puts out news.
Follow AdAlta